Featured News

2023 promises to be a year full of robust research, advocacy, and education efforts on behalf of our patient community.

The American College of Gastroenterology has updated its guidelines for the diagnosis and management of celiac disease, bringing current the recommendations outlined in 2013.

Consider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.

The Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.

On October 13, 2022 the Celiac Disease Foundation hosted the Ask-the-FDA Educational Webinar with representatives from the U.S. Food and Drug Administration and Coeliac UK.

The Celiac Disease Foundation announces its newest appointee, William Thurston, to its Board of Directors.

The month of May is Celiac Disease Awareness Month, and in an effort to bring celiac disease into the public eye, Marilyn G. Geller, Chief Executive Officer of the Celiac…

Anokion SA released successful results from their Phase 1 ACeD clinical trial and they will be moving forward with Phase 2 trials later this year.

We are pleased to announce that CDF Board Member, Kristin Yarema, PhD, was honored as a 2022 Medical Marketing & Media Woman of Distinction.

The Celiac Disease Foundation is pleased to announce the establishment of two international celiac disease research prizes to inspire a new generation of researchers whose work in celiac disease will be invaluable.